Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil combined with topical minoxidil improves hair density in breast cancer patients but may cause excess hair growth.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Dracorhodin perchlorate helps heal wounds in diabetic rats by reducing inflammation.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

Low-dose oral minoxidil is safe for the heart in the short term for hair loss patients.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.

Researchers developed a quick and reliable method to test for betamethasone dipropionate and calcipotriol in ointments and drugs.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Leflunomide with prednisone is effective and well-tolerated for lupus nephritis when cyclophosphamide can't be used.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Low-dose oral minoxidil may be effective for hair loss treatment.

Vitamin D receptor binds similarly to natural and synthetic ligands, affecting gene regulation.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

A fast and accurate method was developed to measure alfuzosin and dutasteride in human plasma.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

The NLC gel with Minoxidil and Finasteride effectively treats hair loss in harsh conditions.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Computational techniques can improve drug development for treating certain conditions.

The research developed new fortilin protein constructs for potential heart disease treatments.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Method measures latanoprost and minoxidil in skin accurately and precisely.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.